阿莱恩斯西部银行 WAL 深 沪
等待开盘 10-13 09:30:00 美东时间
74.69
+0.420
+0.57%
华盛通- 最 高75.46
- 今 开74.58
- 成交量 73.61万股
- 最 低 74.26
- 昨 收 74.27
- 总市值 81.49亿
- 52周最高 95.97
- 市盈率 静 8.55
- 换手率 0.67%
- 52周最低 64.975
- 委 比 2.86%
- 总股本 1.09亿
- 历史最高 117.75
- 量 比 0.52
- 振 幅 1.62%
- 历史最低 -5.44
- 每 手 1
- 风险率 5.70%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅91.5%！巴克莱上调Vertical Aerospace评级至"标配"，目标价下调至1美元
今日重点评级关注：巴克莱：上调Vertical Aerospace评级至"标配"，目标价从2美元降至1美元；巴克莱：维持Bitdeer Technologies"超配"评级，目标价从15美元升至17美元
10-12 14:52
Truist Securities Maintains Buy on Western Alliance, Lowers Price Target to $84
Truist Securities analyst John McDonald maintains Western Alliance (NYSE:WAL) with a Buy and lowers the price target from $93 to $84.
10-09 23:43
美股大行评级 | 瑞银维持康宁“买入”评级，上调目标价至201美元；大摩维持泛林集团“超配”评级
今日重点评级关注：Needham：维持iRhythm Holdings"买入"评级，目标价从192美元升至194美元；HC Wainwright & Co.：维持5E Advanced Materials"买入"评级，目标价从3.5美元升至6.75美元
10-06 16:45
美股大行评级 | 潜在涨幅600.93%！Ascendiant Capital上调Aytu BioPharma目标价至15美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从14.5美元升至15美元；摩根大通：维持Annexon"超配"评级，目标价从14美元升至15美元
10-01 19:18
Wells Fargo Maintains Equal-Weight on Western Alliance, Lowers Price Target to $84
Wells Fargo analyst Terry McEvoy maintains Western Alliance (NYSE:WAL) with a Equal-Weight and lowers the price target from $90 to $84.
09-30 22:40
美股大行评级 | Muse热度发酵，Meta目标价获大幅升至875美元；闪迪获看好至2400美元，潜在升幅约27%
今日重点评级关注：Citizens：上调Quince Therapeutics评级至"跑赢大市"，目标价77美元；康托·菲茨杰拉德：维持塞德斯医疗"超配"评级，目标价从61美元升至72美元
09-23 15:30
Raymond James Initiates Coverage On Western Alliance with Outperform Rating, Announces Price Target of $90
Raymond James analyst David Feaster initiates coverage on Western Alliance (NYSE:WAL) with a Outperform rating and announces Price Target of $90.
09-22 18:11
9 Financials Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders will search for circumstances when the market estimation of an option diverges heavily...
09-02 01:35
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
Wells Fargo Maintains Equal-Weight on Western Alliance, Raises Price Target to $90
Wells Fargo analyst Terry McEvoy maintains Western Alliance (NYSE:WAL) with a Equal-Weight and raises the price target from $79 to $90.
08-11 01:47
